Aug 10, 2026 · 6 min
Berkshire rises on strong buybacks while monday.com and Tenax plunge
Berkshire Jumps, Monday.com Falls, Tenax Plummets
Understanding the stark divergence between cash-rich conglomerates, software firms facing AI disruption, and high-risk biotech ventures reveals the current forces driving market volatility.
- 1Berkshire Hathaway shares climbed following strong operating earnings and a massive four point five billion dollar stock buyback.
- 2Software platform monday.com fell sharply after issuing a weak revenue outlook amid rising artificial intelligence competition.
- 3Tenax Therapeutics suffered a devastating ninety percent stock drop after its Phase three drug trial failed.
Don't miss
Emily Graffeo details the catastrophic ninety percent plunge of Tenax Therapeutics following its failed drug trial.
The brief
Hosts Tim Stenovec and Norah Mulinda sit down with Bloomberg credit reporter Emily Graffeo to unpack the day's major stock market moves, highlighting how shifting corporate earnings and market disruptions are sorting the winners from the losers.
Berkshire Hathaway surged on the back of strong operating earnings and a major 4.5 billion dollar stock buyback, signaling robust health for the conglomerate despite broader economic uncertainties and shifting market dynamics.
Conversely, software firm monday.com faced a sharp decline following a weak revenue forecast, highlighting growing anxieties around artificial intelligence disruption and the company's exposure to private credit markets.
The most dramatic market shock came from Tenax Therapeutics, which saw its stock plummet by nearly 90 percent in a single session after the biotechnology company's Phase 3 drug trial failed to meet its goals.
What was said on this episode
8 statements · 3 positive · 5 negative
Berkshire Hathaway shares rose following positive earnings.
“It was up as much as 3% on some positive earnings.”
Listen at 1:05
Berkshire Hathaway spent about $4.5 billion repurchasing its shares recently.
“The conglomerate said it spent about 4.5 billion to buy back its own stock in the recent quarter.”
Listen at 1:21
Berkshire Hathaway’s manufacturing, service, and retailing gains lifted operating earnings.
“They also had gains in the manufacturing, service and retailing division that helped lift operating earnings over the period.”
Listen at 1:36
AI disruption is causing investors to question software companies’ continued viability.
“investors kind of doubt whether all the software companies that exist continue to need to exist given the disruption from AI.”
Listen at 2:01
Monday.com issued a weaker-than-expected third-quarter revenue forecast.
“They gave a third quarter revenue forecast that was weaker than expected.”
Listen at 2:12
Private credit invested heavily in software companies, followed by a reckoning.
“Private credit just kind of dumped so much money into software names and there's been a little bit of a reckoning.”
Listen at 2:52
Tenax Therapeutics shares fell more than 90% in one day.
“the shares plummeted over 90% today.”
Listen at 3:39
Tenax Therapeutics has about $50 million market capitalization after erasing roughly $450 million.
“It's Only now about $50 million in market cap but of course it had erased about 450 million.”
Listen at 4:18
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Tenax Therapeutics, Inc.
Artificial IntelligenceBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.